News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.
Learn about COVID-19 from infectious disease expert Mini Kamboj.
Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.
Our experts, Drs. Lisa DeAngelis and Jeffrey Drebin, along with current patient, Eliza Paris, share with NBC how at MSK we are still and have always been providing world-class cancer care.
Trending Topics
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.
During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).
Stay Connected with MSK
News Releases
Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.
An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.
Media Coverage
Virtual meetings are becoming the norm under COVID-19 and winning over many researchers. MSK’s Emily Costa is quoted.
Tuesday, June 2, 2020
In an interview with CancerNetwork, MSK’s Kelly Morgan offered background on why the study was conducted in this patient population.
Monday, June 1, 2020
MSK’s Anna Lee discusses latest study on changes in cancer mortality rates.
Monday, June 1, 2020
MSK News
More than 20 years ago, this SKI scientist laid the groundwork for a field that is now transforming medicine.
Computational biology is helping to bring predictive power and precision to oncology.
Claus Torp Jensen seeks to use digital technology at MSK to change the day-to-day experience of cancer care and prevention.
On Cancer Blog
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.
Since the COVID-19 pandemic took hold, a new term has entered our vocabulary: social distancing. What does that mean for people with cancer? Is there different advice about social distancing they should follow?
Learn how cancer patients and survivors can stay active in this time of social distancing.
Find out what cancer survivors should know about the 2019 novel coronavirus outbreak.